Iron Gate Global Advisors’s AbbVie ABBV Stock Holding History

Iron Gate Global Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$374K	Sell	1,488 -5	-0.3%	-$1.08K	0.04%	69
2026 Q1	$325K	Buy	1,493 +63	+4%	+$14K	0.03%	73
2025 Q4	$327K	Buy	1,430 +17	+1%	+$3.87K	0.03%	71
2025 Q3	$328K	Buy	+1,413	New	+$288K	0.03%	75
2025 Q2	–	Sell	-1,160	Closed	-$243K	–	84
2025 Q1	$243K	Sell	1,160 -216	-16%	-$42K	0.03%	76
2024 Q4	$245K	Buy	1,376 +9	+0.7%	+$1.66K	0.03%	77
2024 Q3	$270K	Hold	1,367	–	–	0.04%	71
2024 Q2	$234K	Sell	1,367 -8	-0.6%	-$1.32K	0.04%	82
2024 Q1	$247K	Buy	+1,375	New	+$237K	0.04%	82
2018 Q4	–	Sell	-525	Closed	-$50K	–	78
2018 Q3	$50K	Buy	525 +47	+10%	+$4.46K	0.03%	117
2018 Q2	$44K	Buy	+478	New	+$46.7K	0.03%	93

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Iron Gate Global Advisors's ABBV Position: Q2 2026 in Review

Iron Gate Global Advisors reduced its AbbVie (ABBV) stake by 0.33% in Q2 2026, selling an estimated $1.08K and leaving 1,488 shares worth $374K. The position accounts for 0.04% of the portfolio, ranked #69.

Iron Gate Global Advisors first reported a position in ABBV in Q2 2018 and has held it in 11 quarters since. 4,218 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Iron Gate Global Advisors held 1,488 shares of AbbVie worth $374K as of Q2 2026.
Iron Gate Global Advisors sold 5 AbbVie shares in Q2 2026, an estimated $1.08K.
AbbVie made up 0.04% of Iron Gate Global Advisors's portfolio in Q2 2026, its #69 holding.
Iron Gate Global Advisors first reported a position in AbbVie in Q2 2018 and has held it in 11 quarters since.
4,218 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Iron Gate Global Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.